our team hero image.png

Our Team

Our team is dedicated to bringing innovative solutions that improve the lives of those with Lower Urinary Tract Symptoms. Echoscope is co-founded by two entrepreneurs who have extensive experience in medical device development and healthy living and fitness. Connect with us!

Daryl Chulho Hyun

  • LinkedIn

CEO & Co-founder

 

Daryl was a Biodesign Fellow at the University of Oxford where he researched incontinence and a medical device inventor at BC Cancer Research Center and Harvard Medical School/Mass. General Hospital (MGH). While at MGH, he successfully translated nasal Micro-OCT imaging to the first-in-human clinical trial for cystic fibrosis research. While in the UK & Europe, he was invited to the EIT Health Validation Lab program at Yes!Delft in the Netherlands. Also, he is an avid supporter of the MIT Bootcamp entrepreneur community. Daryl graduated with BSc. in Physics at the University of Waterloo and is studying MSc. Regulatory Affairs at Northeastern University.

Bill Lee, CPA

  • LinkedIn

CFO & Co-founder

 

Bill has practiced accounting for over 8 years in Western Canada. Bill has diverse experiences in different sectors including manufacturing and medical professional corporations as well as non-profit organizations. His expertise in business consultation & planning, taxation, and corporate governance brings foundational values to Echoscope. As an entrepreneur himself, Bill founded a public accounting firm with two other partners in Vancouver. Besides his professional career, Bill is actively involved in the Kitsilano high school basketball team, where he was an all-star player previously.

Hubert Zajicek, MD, MBA

  • LinkedIn

Executive Advisor

 

Hubert is CEO & Co-founder of Health Wildcatters, a nationally top-ranked healthcare accelerator and investment fund in Dallas. The accelerator raises an angel-investor-backed health innovation fund that has invested in 68 healthcare startups, which raised over $100M in the capital in about 7 years with a valuation of half a billion dollars. He serves as an advisor, mentor, and board member on various organizations and startup companies. Prior, he was on faculty at UT Southwestern, as an NIH-funded principal investigator, in the Departments of Internal Medicine and Cell Biology. He has an MD from the University of Vienna and an MBA from Southern Methodist University.

RECOGNIZED BY